The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Tamsulosin Hydrochloride Sustained Release Capsules Market Research Report 2024

Global Tamsulosin Hydrochloride Sustained Release Capsules Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1745645

No of Pages : 98

Ask Your Query

Synopsis
Global Tamsulosin Hydrochloride Sustained Release Capsules market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tamsulosin Hydrochloride Sustained Release Capsules market research.

Key manufacturers engaged in the Tamsulosin Hydrochloride Sustained Release Capsules industry include Astellas Pharma Inc., Shenzhen Wanhe Pharmaceutical Co., Ltd., Zhejiang Conba Pharmaceutical Co., Ltd., Guangdong Huanan Pharmaceutical Group Co., Ltd., Hailisheng Group Co., Ltd., Shanghai Anbison Pharmaceutical Technology Co., Ltd., Jiangxi Shanxiang Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd. and Sandoz Canada, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Tamsulosin Hydrochloride Sustained Release Capsules were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Tamsulosin Hydrochloride Sustained Release Capsules market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tamsulosin Hydrochloride Sustained Release Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Astellas Pharma Inc.
  • Shenzhen Wanhe Pharmaceutical Co., Ltd.
  • Zhejiang Conba Pharmaceutical Co., Ltd.
  • Guangdong Huanan Pharmaceutical Group Co., Ltd.
  • Hailisheng Group Co., Ltd.
  • Shanghai Anbison Pharmaceutical Technology Co., Ltd.
  • Jiangxi Shanxiang Pharmaceutical Co., Ltd.
  • Jiangsu Hengrui Pharmaceuticals Co.,ltd.
  • Sandoz Canada
  • Sanofi
  • Murli Krishna Pharma
  • DM Pharma

Segment by Type

  • Original Drug
  • Generic Drug

Segment by Application

  • Hospital
  • Clinic
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Tamsulosin Hydrochloride Sustained Release Capsules report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Tamsulosin Hydrochloride Sustained Release Capsules Market Overview
1.1 Product Overview and Scope of Tamsulosin Hydrochloride Sustained Release Capsules
1.2 Tamsulosin Hydrochloride Sustained Release Capsules Segment by Type
1.2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Value Comparison by Type (2023-2029)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Tamsulosin Hydrochloride Sustained Release Capsules Segment by Application
1.3.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Size Estimates and Forecasts
1.4.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue 2018-2029
1.4.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales 2018-2029
1.4.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Tamsulosin Hydrochloride Sustained Release Capsules Market Competition by Manufacturers
2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Manufacturers (2018-2023)
2.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Tamsulosin Hydrochloride Sustained Release Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Tamsulosin Hydrochloride Sustained Release Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tamsulosin Hydrochloride Sustained Release Capsules, Product Type & Application
2.7 Tamsulosin Hydrochloride Sustained Release Capsules Market Competitive Situation and Trends
2.7.1 Tamsulosin Hydrochloride Sustained Release Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tamsulosin Hydrochloride Sustained Release Capsules Players Market Share by Revenue
2.7.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tamsulosin Hydrochloride Sustained Release Capsules Retrospective Market Scenario by Region
3.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region: 2018-2029
3.2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region: 2018-2023
3.2.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region: 2024-2029
3.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region: 2018-2029
3.3.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region: 2018-2023
3.3.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region: 2024-2029
3.4 North America Tamsulosin Hydrochloride Sustained Release Capsules Market Facts & Figures by Country
3.4.1 North America Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2029)
3.4.3 North America Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tamsulosin Hydrochloride Sustained Release Capsules Market Facts & Figures by Country
3.5.1 Europe Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2029)
3.5.3 Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tamsulosin Hydrochloride Sustained Release Capsules Market Facts & Figures by Country
3.7.1 Latin America Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2029)
3.7.3 Latin America Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tamsulosin Hydrochloride Sustained Release Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2018-2029)
4.1.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2018-2023)
4.1.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2024-2029)
4.1.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type (2018-2029)
4.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Type (2018-2029)
4.2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Type (2018-2023)
4.2.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Type (2024-2029)
4.2.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Price by Type (2018-2029)
5 Segment by Application
5.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2018-2029)
5.1.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2018-2023)
5.1.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2024-2029)
5.1.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Application (2018-2029)
5.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Application (2018-2029)
5.2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Application (2018-2023)
5.2.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Application (2024-2029)
5.2.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Astellas Pharma Inc.
6.1.1 Astellas Pharma Inc. Corporation Information
6.1.2 Astellas Pharma Inc. Description and Business Overview
6.1.3 Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.1.5 Astellas Pharma Inc. Recent Developments/Updates
6.2 Shenzhen Wanhe Pharmaceutical Co., Ltd.
6.2.1 Shenzhen Wanhe Pharmaceutical Co., Ltd. Corporation Information
6.2.2 Shenzhen Wanhe Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.2.5 Shenzhen Wanhe Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Zhejiang Conba Pharmaceutical Co., Ltd.
6.3.1 Zhejiang Conba Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Zhejiang Conba Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.3.5 Zhejiang Conba Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Guangdong Huanan Pharmaceutical Group Co., Ltd.
6.4.1 Guangdong Huanan Pharmaceutical Group Co., Ltd. Corporation Information
6.4.2 Guangdong Huanan Pharmaceutical Group Co., Ltd. Description and Business Overview
6.4.3 Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.4.5 Guangdong Huanan Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.5 Hailisheng Group Co., Ltd.
6.5.1 Hailisheng Group Co., Ltd. Corporation Information
6.5.2 Hailisheng Group Co., Ltd. Description and Business Overview
6.5.3 Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.5.5 Hailisheng Group Co., Ltd. Recent Developments/Updates
6.6 Shanghai Anbison Pharmaceutical Technology Co., Ltd.
6.6.1 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Corporation Information
6.6.2 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Description and Business Overview
6.6.3 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.6.5 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
6.7 Jiangxi Shanxiang Pharmaceutical Co., Ltd.
6.6.1 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.7.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
6.8.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Corporation Information
6.8.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
6.8.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.8.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
6.9 Sandoz Canada
6.9.1 Sandoz Canada Corporation Information
6.9.2 Sandoz Canada Description and Business Overview
6.9.3 Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.9.5 Sandoz Canada Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
6.11 Murli Krishna Pharma
6.11.1 Murli Krishna Pharma Corporation Information
6.11.2 Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Description and Business Overview
6.11.3 Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.11.5 Murli Krishna Pharma Recent Developments/Updates
6.12 DM Pharma
6.12.1 DM Pharma Corporation Information
6.12.2 DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Description and Business Overview
6.12.3 DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue and Gross Margin (2018-2023)
6.12.4 DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolio
6.12.5 DM Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tamsulosin Hydrochloride Sustained Release Capsules Industry Chain Analysis
7.2 Tamsulosin Hydrochloride Sustained Release Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tamsulosin Hydrochloride Sustained Release Capsules Production Mode & Process
7.4 Tamsulosin Hydrochloride Sustained Release Capsules Sales and Marketing
7.4.1 Tamsulosin Hydrochloride Sustained Release Capsules Sales Channels
7.4.2 Tamsulosin Hydrochloride Sustained Release Capsules Distributors
7.5 Tamsulosin Hydrochloride Sustained Release Capsules Customers
8 Tamsulosin Hydrochloride Sustained Release Capsules Market Dynamics
8.1 Tamsulosin Hydrochloride Sustained Release Capsules Industry Trends
8.2 Tamsulosin Hydrochloride Sustained Release Capsules Market Drivers
8.3 Tamsulosin Hydrochloride Sustained Release Capsules Market Challenges
8.4 Tamsulosin Hydrochloride Sustained Release Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock